Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc. for the support Promega custom manufacturing provided in the rapid development and launch of the new Logix Smart™ COVID-19 Test. Co-Diagnostics yesterday afternoon announced its coronavirus test received CE mark approval and is now available in Europe as an in vitro diagnostic (IVD). The news comes roughly one month after Co-Diagnostics first began work on a test to detect SARS-CoV-2, the virus that causes COVID-19.
